BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30627372)

  • 1. Involvement of central opiate receptors in modulation of centrally administered oxytocin-induced antinociception.
    Erfanparast A; Tamaddonfard E; Seyedin S
    Iran J Basic Med Sci; 2018 Dec; 21(12):1275-1280. PubMed ID: 30627372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intra-fourth ventricle injection of crocin on capsaicin-induced orofacial pain in rats.
    Tamaddonfard E; Tamaddonfard S; Pourbaba S
    Avicenna J Phytomed; 2015; 5(5):450-7. PubMed ID: 26468465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central H
    Erfanparast A; Tamaddonfard E; Henareh-Chareh F
    Vet Res Forum; 2020; 11(3):229-234. PubMed ID: 33133459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of oxytocin in spinal antinociception in rats with inflammation.
    Yu SQ; Lundeberg T; Yu LC
    Brain Res; 2003 Sep; 983(1-2):13-22. PubMed ID: 12914962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.
    Erfanparast A; Tamaddonfard E; Taati M; Dabaghi M
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1089-96. PubMed ID: 26077661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.
    Tamaddonfard E; Erfanparast A; Salighedar R; Tamaddonfard S
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):371-379. PubMed ID: 31641818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
    Gao L; Yu LC
    Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
    Yousofizadeh S; Tamaddonfard E; Farshid AA
    Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intra-hippocampal microinjection of vitamin B
    Erfanparast A; Tamaddonfard E; Nemati S
    Physiol Behav; 2017 Mar; 170():68-77. PubMed ID: 27998753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
    Gu XL; Yu LC
    J Pain; 2007 Jan; 8(1):85-90. PubMed ID: 17097925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat.
    Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB
    Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thalamic ventral posterolateral nucleus histamine H
    Ghasemi H; Tamaddonfard E; Soltanalinejad F
    Pharmacol Rep; 2017 Dec; 69(6):1393-1401. PubMed ID: 29145067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats.
    Okumura T; Nozu T; Kumei S; Ohhira M
    Physiol Behav; 2019 Jan; 198():96-101. PubMed ID: 30342057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pilocarpine on the formalin-induced orofacial pain in rats.
    Tamaddonfard E; Erfanparast A; Khalilzadeh E
    Vet Res Forum; 2012; 3(2):91-5. PubMed ID: 25653753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of mu-opioid receptor.
    Wang JW; Lundeberg T; Yu LC
    Regul Pept; 2003 Oct; 115(3):153-9. PubMed ID: 14556956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat.
    Spreekmeester E; Rochford J
    Psychopharmacology (Berl); 2000 Jan; 148(1):99-105. PubMed ID: 10663423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats.
    Xie YF; Wang J; Huo FQ; Jia H; Tang JS
    Neuroscience; 2004; 126(3):717-26. PubMed ID: 15183520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists.
    Maldonado R; Negus S; Koob GF
    Neuropharmacology; 1992 Dec; 31(12):1231-41. PubMed ID: 1335131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.